Press + media
Media kit.
Brand assets, boilerplate, quotable statements, and fact sheet for journalists, podcasters, and commerce aggregators covering the research-peptide category.
Company boilerplate
Aurex is a US-based research-grade peptide distributor. Every batch is independently re-verified at Janoshik Analytical (HPLC-UV, mass spectrometry, identity confirmation) before release. Kits ship lyophilized, vacuum-sealed, and tamper-evident for domestic US research labs, with every vial linking to a QR-accessible COA and a 100% purity-replacement guarantee. All compounds are distributed strictly for in-vitro laboratory research by qualified researchers.
Use this block as-is in press coverage.
Fact sheet
| Founded | 2026 |
| HQ | United States |
| Category | Research-grade peptide distribution |
| Third-party lab | Janoshik Analytical |
| Minimum purity threshold | 97% HPLC-UV |
| Payment rails | Crypto, Zelle, ACH, domestic wire (NMI credit-card Phase 2) |
| Shipping | Domestic US only at launch (international Phase 2) |
| Guarantee | 100% purity-replacement within 60 days |
| Launch | 2026-07-16 |
Brand assets
Aurex wordmark — SVG
Primary logotype, vector
Aurex icon — SVG
Square icon mark, vector
Aurex icon — PNG 512×512
Raster icon for social and press placements
Open Graph social card
1200×630 dynamic OG card
Full brand guide available on request via press@aurex.bio.
Quotable statements
“Aurex exists because researchers deserve transparency. Every vial links to its Janoshik COA by QR code, every batch passes a third-party retest before it ships, and every order is backed by a no-friction replacement guarantee. If any Aurex kit fails at an accredited lab, we reship and the researcher keeps the original.”
“The standard for serious research is simple: independent verification on every lot, visible purity data on every vial, and packaging that arrives stable and discreet. No secret formulas, no lot-dodging, no reseller opacity.”